JGH: Correlation between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes

Fatalities in Type 2 Diabetes (T2D) PatientsHeart vascular risk events 2-4 times higher than the normal population, all T2D patients with cardiovascular disease (CVD) affects approximately 32.
2% of the world, but also the leading cause of death in patients with T2D
.

The traditional risk factors for cardiovascular disease are hypertension, obesity, reduced physical activity, smoking, diabetes, and hypertension

Fatalities in Type 2 Diabetes (T2D) PatientsHeart vascular risk events 2-4 times higher than the normal population, all T2D patients with cardiovascular disease (CVD) affects approximately 32.

 

The researchers recruited 1,481 patients who started oral hypoglycemic drugs for newly diagnosed T2D between 2006 and 2010
.

Fibrosis index-4 (FIB-4), non-alcoholic fatty liver disease fibrosis score (NFS) and BARD score are used to assess the burden of liver fibrosis at the time of T2D diagnosis

diagnosis

 

During the follow-up period, 242 (16.
3%) patients had a CVD event
.

Cardiovascular disease often occurs in elderly patients and is related to hypertension; it is also related to lower platelet counts and higher FIB-4, NFS and BARD scores (P<0.

Metabolic syndrome

 

This study confirmed that the severity of liver fibrosis independently predicted the incidence of CVD in T2D patients
.

Therefore, the assessment of liver fibrosis may enable doctors to optimize the timing of appropriate cardiovascular interventions for such patients

This study confirmed that the severity of liver fibrosis independently predicted the incidence of CVD in T2D patients

 

Original source:

Ho Soo Chun.

Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes.
Leave a message here